Ticker Details
Fennec Pharmaceuticals Inc. Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities.
IPO Date:	September 11, 2017
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$395.91M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.20 | 2.80%
Avg Daily Range (30 D):	$0.32 | 2.95%
Avg Daily Range (90 D):	$0.28 | 3.07%

Institutional Daily Volume
Avg Daily Volume:	.1M
Avg Daily Volume (30 D):	.15M
Avg Daily Volume (90 D):	.2M

Trade Size
Avg Trade Size (Sh.):	115
Avg Trade Size (Sh.) (30 D):	52
Avg Trade Size (Sh.) (90 D):	62

Institutional Trades
Total Institutional Trades:	53
Avg Institutional Trade:	$2.62M
Avg Institutional Trade (30 D):	$3.95M
Avg Institutional Trade (90 D):	$2.06M
Avg Institutional Trade Volume:	.32M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$4.97M
Avg Closing Trade (30 D):	$5.34M
Avg Closing Trade (90 D):	$2.37M
Avg Closing Volume:	597.36K

News

Dec 26, 2025 @ 10:44 PM Southpoint holdings in Fennec Pharmaceuticals Inc.... Source: Na

Nov 14, 2025 @ 4:11 AM Fennec Pharmaceuticals Announces Private Offering ... Source: Fennec Pharmaceuticals Inc.

Nov 14, 2025 @ 4:07 AM Fennec Pharmaceuticals Announces Pricing of Offeri... Source: Fennec Pharmaceuticals Inc.

Aug 14, 2025 @ 3:04 PM Fennec Q2 Sales Jump 33 Percent Source: Na

Jun 3, 2025 @ 8:31 PM Fennec Announces Results of Annual Meeting Source: N/A

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-.12	$.06	$.01
Diluted EPS	$-.12	$.05	$.01
Revenue	$59.22M	$17.87M	$15.11M
Gross Profit
Net Income / Loss	$-3.25M	$1.97M	$.2M
Operating Income / Loss	$-1.13M	$1.74M	$-.12M
Cost of Revenue
Net Cash Flow	$M	$M	$M
PE Ratio

Splits
Sep 05, 2014	1:3
Aug 30, 2011	1:18
Aug 02, 2005	1:5